Targeted Treatment for Hyperprolactinemia and Related Disorders. Cabergoline 0.5mg is a first-line medical therapy for conditions caused by excessive production of prolactin.
Primary Medical Indications include Hyperprolactinemia, Prolactin-Secreting Adenomas, Restoration of Ovarian & Testicular Function, Galactorrhea, and Parkinson’s Disease.
- Dosing: Treatment usually begins at a low dose, such as 0.25mg twice per week.
- Convenience: Its long half-life allows for once- or twice-weekly dosing.
- Tumor Reduction: Can effectively shrink prolactin-secreting pituitary macroadenomas.





Reviews
There are no reviews yet.